GLP-1 research, clearly explained.
What the trials found. What the label says. What your prescriber needs to know. Every claim cites its primary source.
Retatrutide just posted up to 30% weight loss. What it means for women.
The triple agonist behind the field’s biggest trial number: the science, the comparison, and the muscle stakes, with every claim cited.
1 in 4 people on a GLP-1 still report frequent food noise, a national survey finds
A Penn State survey of 1,000 US adults, published on 26 September 2026, found 25.76% of current GLP-1 users said they experience food noise often or always, against 16.30% of…
Do GLP-1s protect your kidneys? A 75,455-person study says it depends on one urine test
A BMJ study of 75,455 adults with type 2 diabetes, published on 16 September 2026, found GLP-1 and SGLT-2 medicines cut the risk of kidney decline by 40% in people with protein in…
Which GLP-1 carries the most eye risk? A new NAION analysis compares them
A network meta-analysis published on 21 September 2026 ranked GLP-1 medicines by their link to NAION, a rare optic nerve stroke. Semaglutide came out highest, at about one and a…
Took a GLP-1 before you knew you were pregnant? What 2.1 million pregnancies show
The largest review yet, published in Med on 29 September 2026, found no clear rise in miscarriage, birth defects or preterm birth after GLP-1 exposure around conception. It is…
Do GLP-1s harm teenagers' mental health? A study of 18,444 adolescents
A study of 18,444 teenagers with obesity, published on 14 September 2026, found no rise in psychiatric problems on semaglutide, liraglutide or tirzepatide, and fewer…
After stopping a GLP-1, an app or delivered meals cut regain by about two-thirds in a small trial
In a 39-person pilot trial published on 7 October 2026, people who stopped a GLP-1 and got no structured support gained an estimated 10.75% of body weight in four months. Those…
Is semaglutide right if you are older or frail? What the SELECT trial found
A new analysis of 17,604 people in the SELECT trial, published in JAMA Cardiology on 16 September 2026, found semaglutide's heart benefits held across frailty levels, and the…
How much weight will you lose on semaglutide? SELECT found it cannot be predicted, and the peak came at 19 months
An analysis of 7,594 people in the SELECT trial, published on 24 September 2026, found a median peak weight loss of 12.5% on semaglutide, reached after a median of 19 months. Age,…
Tirzepatide with a set diet and activity plan: 35% less fat and muscle held in 6 months, a clinic study reports
A Palermo clinic study of 122 adults, published on 25 September 2026, paired tirzepatide with a standardised low-carbohydrate diet and tailored activity. After 24 weeks, fat mass…
Some weight comes back on tirzepatide, even while you keep taking it. Three years of SURMOUNT-1 show how much
A SURMOUNT-1 analysis published on 18 September 2026 tracked 690 people on tirzepatide for over three years. 70% regained less than 5% of their starting weight after their lowest…
Why a GLP-1 alone is not enough: what the trials actually tested
Wegovy and Zepbound were never tested on their own. In the trials they came with diet and exercise advice, and the people who stopped regained most of the weight. What the shot…
Ozempic breakfast recipes worth getting up for: waffles, pancakes and a Gruyère quiche
Five Ozempic breakfasts that eat like brunch, with the protein built into the dish rather than added on the side. Every figure is calculated per serving.
GLP-1s, your teeth and your gums
Less saliva, more acid reflux, occasional vomiting and a smaller diet all reach your mouth before they reach anywhere else. What the periodontal research suggests about these…
Semaglutide and how far you can walk: the STRIDE result
A randomised trial measured something most obesity trials never touch: whether people could walk further afterwards. In peripheral artery disease with type 2 diabetes, semaglutide…
What actually changes about what you eat on a GLP-1
The medicine does not only make you eat less. It changes which foods you want, how far into a meal you get, and the balance of what ends up on the plate. What the feeding studies…
GLP-1s and your eyes: what the NAION evidence actually says
Three large studies asked whether semaglutide raises the risk of a rare form of sudden vision loss and came back with three different answers. What NAION is, why the studies…
Why most people stop within a year, and what makes staying on it easier
Fewer than a third of people are still taking their GLP-1 twelve months later, and a fifth stop almost immediately. What the discontinuation research says about why, what repeated…
Tirzepatide or semaglutide with niacinamide, B12 or glycine: what the added ingredient does
Compounded tirzepatide and semaglutide are often sold with niacinamide, vitamin B12, B6 or glycine added. Why those combinations exist, what each ingredient actually does, whether…
Food noise coming back on Mounjaro or Wegovy: why it happens, and what helps
The quiet in your head was the best part, and now the chatter about food is creeping back. What food noise actually is, the likely reasons it returns while you are still on the…
Microdosing GLP-1s for inflammation, joint pain and a calmer mind: what the evidence shows
People microdose tirzepatide and semaglutide hoping for less inflammation, less joint pain, calmer autoimmune symptoms or a quieter mind. What the trials show at licensed doses,…
Microdosing a GLP-1 in perimenopause or menopause: what is known, and what is not
Low-dose tirzepatide and semaglutide are marketed hard to women in midlife. Here is what the evidence actually covers, what it does not, the risks that come from how people…
Staying on a lower GLP-1 dose: what the first maintenance trial found
Reached your goal and wondering whether to stay, step down or stop? A 2026 trial tested dropping tirzepatide to 5 mg for a year. What it found, what stopping does, and what is…
Still hungry on Mounjaro or Wegovy? Why it happens, and what to do
Hungry on a GLP-1, or hungrier after a dose increase? The likely reasons, from low starting doses and long gaps between meals to the end of the injection week and your period, and…
Sulphur burps and gas on Mounjaro or Wegovy: why they happen, and what helps
Eggy burps, wind and bloating are listed side effects of Mounjaro and Wegovy. How common they are, why they can smell of sulphur, what to eat and avoid, why salad can suddenly…
The Wegovy pill: how to take it, and what to eat around it
The Wegovy pill is semaglutide as a daily tablet, and it only works if you take it exactly right. The empty stomach, the sip of water, the 30-minute wait, what to eat for…
How many calories should you eat on a GLP-1?
There is no official calorie number for Ozempic, Wegovy or Mounjaro. Here is how a sensible target is worked out, why appetite often decides the total, and the floor to stay above.
Vegetarian or vegan on a GLP-1: how to get enough protein
Vegetarian and vegan eating works on Ozempic, Wegovy or Mounjaro, but protein needs a plan. What the evidence says about plant protein, what our own recipe data shows, and the…
Your first week on a GLP-1: what to eat while your body adjusts
The first week on Ozempic, Wegovy or Mounjaro is the lowest dose, and the one your digestion is still getting used to. Small plain meals, protein first, plenty to drink, and the…
A GLP-1 grocery list: what to keep in, and why
A shopping list for a smaller appetite, built from the ingredients our GLP-1 recipes use most: protein you do not have to cook, fibre that is easy to eat, and a shelf for the days…
What to eat on injection day, and in the days after
You do not need to eat, or fast, before an Ozempic, Wegovy or Mounjaro injection. What the prescribing information actually says about food and timing, and how to plan meals…
What to eat on Mounjaro: a practical plate for tirzepatide
There is no official Mounjaro diet. There is a better way to eat on it: protein first, smaller plates, fibre with fluid, and extra care in the weeks after each dose increase.
What to eat on Wegovy: a practical plate for semaglutide
There is no official Wegovy diet. There is a better way to eat on it: protein first, smaller plates, fibre with fluid, and extra care while the dose is climbing.
GLP-1s and sleep apnoea: what a 20-point drop in AHI actually means
Tirzepatide became the first medicine licensed for moderate to severe obstructive sleep apnoea in adults with obesity. What the SURMOUNT-OSA trials found, how it compares with…
GLP-1s and disordered eating: the question nobody is screening for
A medicine that removes hunger can quiet a difficult relationship with food, or hide one. What specialists have learned from bariatric surgery about symptoms going unnoticed, the…
Fasting for Ramadan on a GLP-1: what the evidence shows
A long daylight fast and a medicine that quietens appetite pull in the same direction, which is the difficulty. What real-world studies of GLP-1s during Ramadan found, how to…
Protein powder on a GLP-1: when a shake is the sensible answer
A shake is not a shortcut, it is a way of getting protein in when appetite will not allow a plate of food. Which type to pick, how much a scoop really gives you, when a liquid…
What to eat on orforglipron, the GLP-1 pill with no timing rules
Orforglipron, sold as Foundayo, is the first GLP-1 tablet for weight loss that can be taken at any hour, with food or without. What that changes about your day, what it does not,…
Surgery on a GLP-1: what the guidance actually says now
The advice on stopping a GLP-1 before an operation changed in 2024, and a lot of people are still being told the old version. What the multisociety guidance says about continuing…
GLP-1 Snacks and Eating Out: The Restaurant Playbook Nobody Gives You
GLP-1 snacks and eating out at a restaurant, handled: 12 protein-forward snacks with grams, how to order, and what to say when someone comments.
GLP-1 breakfast high protein ideas: 10 that work when you're not hungry
GLP-1 breakfast high protein ideas with real gram counts: 10 cold, savoury and sippable options for mornings when nothing sounds good.
Fibre on GLP-1: The Constipation Fix, and How to Reach 25-35g Without Bloating
Fibre on GLP-1 constipation: why the medication hardens stool, how to reach 25-35g a day without bloating, and when psyllium actually helps.
A 7 Day GLP-1 Meal Plan: Portions, Protein and a Shopping List
A free 7 day GLP-1 meal plan with real portions, protein per day, a shopping list by aisle, and a smaller version for the days nausea wins.
Foods to Avoid on GLP-1: The Honest List, and Why Each One Hurts
Foods to avoid on GLP-1, handled honestly. Almost nothing is banned, but seven things reliably make a slow stomach feel worse. Here is the mechanism for each.
GLP-1 Diet Foods to Eat: The List for a Very Small Appetite
GLP-1 diet foods to eat, ranked by protein and fibre per mouthful. Real gram figures, the order to eat in, and what to assemble on a low-energy day.
Exercise on a GLP-1: how much cardio, how much strength, on a tired body
You do not need to punish yourself to protect your results on a GLP-1. Here is the realistic split of strength and cardio for women, built around a lower-energy body.
GLP-1s and dry mouth, bad breath and your teeth: the oral-health side no one mentions
Dry mouth, bad breath and acid from occasional vomiting can quietly affect your teeth on a GLP-1. Here is the simple dental routine that protects your smile while you lose weight.
GLP-1s and gut health: fibre, the microbiome, and a calmer digestion
GLP-1s slow the gut, which is why constipation and bloating are so common. Here is how fibre, fluids and a few habits keep your digestion, and your microbiome, on your side.
GLP-1 medicines and anxiety: what the research actually shows
Some people feel calmer on Ozempic, Wegovy or Mounjaro. Others feel more anxious. The research points both ways depending on how it was done. What the trials, the large record…
Travelling with a GLP-1: how to store your pen, cross time zones, and pack right
A weekly injection should not stop you travelling. Here is the practical, calm guide to storing your GLP-1, flying with it, and handling time zones and dose day on the road.
Eating less on a GLP-1: how to avoid nutrient gaps when appetite is low
When you eat a fraction of what you used to, it is easy to fall short on protein, iron, calcium and B12. Here is how women can keep the nutrients in while the calories come down.
GLP-1s and libido: what happens to sex drive on Ozempic and Wegovy
Some women notice their sex drive changes on a GLP-1. The picture is mixed and mostly indirect. Here is what is really going on, and what helps, in plain language.
GLP-1 microdosing: what it means, what the evidence shows, and the real risks
Microdosing tirzepatide and semaglutide is everywhere online. What people mean by it, why they do it, what the few studies of lower doses actually found, and where the real risks…
GLP-1s and menopause: why the drug still works, and what to protect
Menopause changes where you gain weight and how fast you lose muscle. New analyses show GLP-1s work just as well after menopause, if you protect muscle and bone. Here is how.
What to eat on Ozempic: a protein-first plate for women on a GLP-1
You are eating far less on a GLP-1, so every bite has to earn its place. Here is the simple, protein-first way to eat on Ozempic, Wegovy, Mounjaro or Zepbound, without the…
Tirzepatide vs Semaglutide: A Calm Decision Guide for Women
Tirzepatide vs semaglutide, explained for women on GLP-1: how each molecule works, the head-to-head evidence, side effects, and the real decision criteria.
GLP-1 Joint Pain and Knee Osteoarthritis: What the Research Actually Shows
GLP-1 joint pain and knee osteoarthritis: STEP-9 cut knee pain in mostly women, and new research hints at cartilage benefit beyond weight loss. The honest picture.
Loose skin after weight loss: what is real, what helps, and what to ignore
Loose skin is one of the most common worries women have about losing a lot of weight on a GLP-1. Here is the honest version: what causes it, what genuinely helps, and which…
GLP-1, the Brain, Dementia and Mood: The Honest Picture
What we know about GLP-1, brain, dementia and mood: lower dementia and addiction risk in observational data, but no benefit in early Alzheimer disease.
Food noise: what it is, and why GLP-1 medicines turn it down
Many people on Ozempic, Wegovy or Mounjaro say the constant chatter about food goes quiet. Food noise now has a formal definition and a questionnaire. What it is, what the trials…
Beyond weight: how GLP-1s calm inflammation, and why that quietly helps women most
The cancer findings, the heart findings, the autoimmune findings: a single thread runs under this year's GLP-1 research. These drugs lower inflammation. Here is what that means,…
Ozempic Shame, Stigma, and Judgment: The GLP-1 Paradox, and Why It Is Misplaced
A Rice University study found GLP-1 users judged more harshly than dieters, even than non-losers. Here is why the Ozempic shame, stigma, and judgment is misplaced.
GLP-1s and your kidneys: the quiet organ these drugs may actually protect
Lost in the weight-loss headlines is one of the strongest findings about these drugs: they appear to protect the kidneys. For women with diabetes, PCOS or high blood pressure,…
Why Weight Comes Back After Ozempic: The Set Point, Explained
Why weight comes back after Ozempic is biology, not failure. How the set point, hormone rebound, and lost muscle work, and the one lever you control.
GLP-1s and fertility: the 'Ozempic baby' surprise, and the contraception catch no one mentions
Women on GLP-1s are reporting unexpected pregnancies, sometimes after years of trying. The reason is real biology, and it comes with a contraception warning that too few are told.…
The side effect no one mentions: you move less on a GLP-1, and you don't notice
New data presented in 2026 found that as women lost weight on these drugs, they also took fewer steps and did less moderate activity, without realising it. That quiet drop is…
GLP-1s and cancer risk: what the new breast-cancer headlines actually say
Two 2026 studies linked GLP-1 medications to a large drop in obesity-related cancers, including roughly 30% lower breast cancer risk in women. Encouraging, real, and easy to…
GLP-1s and fatty liver: what the new MASH approval actually means for you
Fatty liver is common, quiet, and more frequent in women than most people realise. In 2025 and 2026, GLP-1 medications became the first drugs approved to treat its serious form.…
GLP-1s and your heart: the protection that starts before the weight comes off
Ozempic and Mounjaro do more than shrink the scale. They lower the risk of heart attack and stroke, and the latest data shows the protection begins early, before most of the…
What 30% weight loss means for women: retatrutide, muscle, and the higher stakes
The biggest weight-loss number the field has seen is also the biggest test of a quiet truth: the more you lose, the more muscle is on the line. For women, with less muscle to…
Retatrutide vs tirzepatide vs semaglutide: how to think about the triple agonist
One receptor, two, or three. The numbers climb with each. But the drug that wins on a trial chart is not always the one that's right for you, and the newest one isn't available…
Retatrutide, explained: the triple agonist behind 30% weight loss
Lilly's TRIUMPH-1 trial just reported the highest weight loss the field has seen, up to 30% of body weight. Here is what retatrutide actually is, what the numbers mean, and the…
Alcohol on a GLP-1: what changes, what doesn't, and the one drink that catches everyone out
The drug doesn't ban alcohol. Your body just reads it differently now. Here's what the early evidence shows about why drinking on a GLP-1 feels strange, and the practical rules…
GLP-1s and the pill: a warning women on Mounjaro and Zepbound need to read
Tirzepatide can reduce the effectiveness of oral contraceptives. The label is clear about it; the conversation often isn't. Here is what to know, what to switch to, and for how…
Gallbladder risk on a GLP-1: what to watch for, and what protects you
Fast weight loss is the biggest single risk factor for gallstones. GLP-1s deliver fast weight loss. Here is what the data shows about the actual risk, and the small things that…
Hydration on a GLP-1: why your thirst is lying and what to do about it
The drug doesn't only quiet hunger. It quiets thirst too. The result is a low-grade dehydration that drives nausea, fatigue, constipation, and headaches. Here is the simple rule…
Mood, anxiety, and GLP-1s: what the data actually shows
There were reports. There were FDA reviews. There were headlines. Here is a careful look at what the suicidality and mental-health data on GLP-1s really says, and what to do if…
GLP-1s and PCOS: what the early evidence shows for women with insulin resistance
Polycystic ovary syndrome and GLP-1 weight loss interact in ways that are still being studied. Here is what the small but growing literature shows about cycles, fertility, and…
GLP-1s in perimenopause: why the same dose hits different
The years before menopause change body composition, insulin sensitivity, and how a GLP-1 feels. Here is what shifts, and the small adjustments that make the medication work with…
GLP-1s and pregnancy: the two-month wash-out you need to plan for
GLP-1s are not approved for use in pregnancy. The standard guidance is to stop the medication two months before trying to conceive. Here is the reasoning, the gap in the data, and…
GLP-1s and sleep: better, worse, or both?
Some women sleep better the moment they start. Others develop new acid reflux at 3am for the first time in their lives. Here is what the literature says, and what to do if the…
The thyroid black-box warning, explained for women on a GLP-1
Every GLP-1 label carries the same warning about thyroid tumours. The animal data is real. The human signal so far is small. Here is what to actually do with that information.
Bone density on a GLP-1: a quiet question worth asking
Rapid weight loss has always affected bone. The GLP-1 era is a new test of an old finding. Here is what the early data shows, and the three small habits that protect your skeleton…
Compounded semaglutide and tirzepatide: what is, and isn't, the same
When supply ran short, compounded versions of GLP-1s flooded the market. With the shortages over, US compounders can no longer sell copies of the approved medicines. Here is what…
Constipation on a GLP-1: the fibre, water, magnesium loop that actually works
Slower gastric emptying is how GLP-1s work. It is also why roughly one in four people on semaglutide develop constipation. Here is the protocol that fixes it without bringing back…
How to make your GLP-1 doctor's visit actually useful
Ten minutes goes fast. Most women leave the appointment without having asked the questions that would have changed the next three months. Here is the worksheet to walk in with.
GLP-1 fatigue: why month two flattens you, and what to do about it
The exhaustion that hits at week six is one of the least talked-about side effects of GLP-1s. Here is the math behind it, not enough food, not enough protein, not enough…
GLP-1s and gastroparesis: separating the noise from the signal
Reports of severe stomach paralysis on GLP-1s made headlines in 2023. The data since has been more careful. Here is what gastroparesis is, who it actually happens to, and the…
How to rotate your GLP-1 injection sites, and why it matters more than you think
Always the same spot. Always the same time. Always the same low-grade lump under the skin. Here is the rotation pattern that prevents lipohypertrophy, and the technique notes most…
Insulin resistance on a GLP-1: the metabolic marker that often changes first
The scale is the slowest line on the chart. Insulin resistance often improves before the weight changes meaningfully, sometimes within weeks. Here is what that means, and what to…
Pancreatitis on a GLP-1: rare, real, and exactly what to watch for
Acute pancreatitis on a GLP-1 is uncommon, but it is the side effect that earns a label warning for a reason. Here are the exact signs that should send you to A&E, and the people…
The month-four plateau on a GLP-1: why it happens, and what to do about it
The first eight weeks fly. Then the scale stops. This is not the drug failing, it is your body doing what bodies do. Here's the maths, and the three levers that move it again.
What happens when you stop a GLP-1, and how to plan for it
Stopping Wegovy, Ozempic or Mounjaro brings much of the weight back for most people, and the trials show how much and how fast. Why it happens, what the evidence says about…
Strength training on a GLP-1: a programme that fits a tired, hungry body
You don't need a gym membership. You need two sessions a week, each twenty to thirty minutes, that hit the muscles your body would otherwise quietly let go of. Here is the…
Pausing your titration: the dose-hold most prescribers don't mention
Standard GLP-1 protocols climb the dose every four weeks. Nothing in the label requires that. The pause that protects skin, muscle, and mood is one of the most useful, and least…
Mounjaro vs Wegovy: how to think about the choice
Tirzepatide loses more weight on average. Semaglutide has more years of safety data. The right answer is rarely about averages, here's the framework your prescriber is probably…
Ozempic face: what it is, what helps, what doesn't
Loose skin and a hollow look after fast weight loss has a name now. It isn't the drug, it's the speed. Here's what the evidence says about slowing it down without slowing your…
Your cycle and your GLP-1: why month three feels like four different medications
Gastric emptying, appetite, and water retention shift across the menstrual cycle, and GLP-1s stack on top. A phase-by-phase guide.
Hair shedding on Ozempic: why it happens at month three, and what actually helps
Telogen effluvium is the medical name. Rapid weight loss is the trigger. Protein, iron, and patience are most of the answer.
Muscle on a GLP-1: the 2-hour-a-week rule that changes everything
Protein alone slows muscle loss. Protein plus two short resistance sessions a week preserves it. The evidence, and a practical starting plan.
Nausea on a GLP-1: what helps, and when to get help
Nausea is the most common stomach side effect of Ozempic, Wegovy and Mounjaro. How common it is, how long it lasts, what the NHS and the experts suggest, where ginger fits, and…
Why 120 grams of protein matters when you can barely eat breakfast
Up to 40 per cent of the weight lost on a GLP-1 can be lean mass rather than fat. Here is what the research says about protecting it when appetite disappears.
One email a week. One new study, one thing we learned.
No spam. No affiliate links. Unsubscribe in one click. We send it on Sunday mornings, so you can read it with coffee or leave it unopened. Nothing is lost either way.